Abstract:
This invention relates to a method of treating diabetes and diabetes-related disorders. Specifically, the method of the present invention relates to administering a single compound that lowers blood glucose levels, lowers serum triglyceride levels, and increases serum high density lipoproteins (HDL) levels thereby providing a treatment option for individuals afflicted with a metabolic disorder such as diabetes mellitus, insulin resistance, impaired glucose tolerance, and dyslipidemia.
Abstract:
The present invention relates to a method for preparing pseudo islets. In addition, the invention is also directed to methods of treating diabetes and diabetes-related disorders by administering compounds identified by the methods described herein.
Abstract:
This invention relates to a method of treating diabetes and diabetes-related disorders. Specifically, the method of the present invention relates to administering a single compound that lowers blood glucose levels, lowers serum triglyceride levels, and increases serum high density lipoproteins (HDL) levels thereby providing a treatment option for individuals afflicted with a metabolic disorder such as diabetes mellitus, insulin resistance, impaired glucose tolerance, and dyslipidemia.
Abstract:
The present invention relates to a method for preparing pseudo islets. In addition, the invention is also directed to methods of treating diabetes and diabetes-related disorders by administering compounds identified by the methods described herein.
Abstract:
This invention relates to novel indane acetic acid derivatives of formula (I) which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also relates to intermediates of formula (II) and (III) of indane acetic derivatives and to methods of preparation.